The only diference this time Pro is that they stated they were expecting a deal this half. From the 4D:
Milestones for next 12 months
• Complete recruitment for STEP trial
• Secure manufacturing and commercial partner for Progenza in Japan - H2 FY16!!!!
• Report on preliminary safety for Progenza STEP trial
• Report on Kvax osteosarcoma trial
• Report on CryoShot Canine pre-pivotal trial
• Complete recruitment for ACTIVATE cancer vaccine trial
RGS Price at posting:
16.0¢ Sentiment: Buy Disclosure: Held